Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Merle L. Myerson"'
Autor:
Kerrilynn C. Hennessey, Emily P. Zeitler, Terrence D. Welch, Shayne E. Dodge, Rachel C. Forcino, Kinan Bachour, Merle L. Myerson, Pablo Martinez-Camblor, Pamela S. Douglas, Megan J. Coylewright
Publikováno v:
JACC: Advances. 2:100312
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f28a76e423c290913d15aab9cf7fc429
https://doi.org/10.1016/j.jacadv.2023.100312
https://doi.org/10.1016/j.jacadv.2023.100312
Publikováno v:
Drugs - real world outcomes. 9(1)
Limited evidence-based therapies exist for the management of heart failure with preserved ejection fraction (HFpEF). Sodium-glucose cotransporter-2 inhibitor (SGLT2i) use in patients with systolic heart failure (HFrEF) and type-2-diabetes mellitus (T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c43b9bc524a59587633513a5e8a0f117
https://pubmed.ncbi.nlm.nih.gov/34478119
https://pubmed.ncbi.nlm.nih.gov/34478119
Autor:
Merle L. Myerson, Dianna Gaballa, Rodis Paparodis, Robert A. Wild, Eugenia Gianos, Maya Balakrishnan, Dean G. Karalis, Eliot A. Brinton, Guy Mintz
Publikováno v:
Journal of clinical lipidology. 15(3)
A recent rise in atherosclerotic cardiovascular disease (ASCVD) mortality in women warrants a heightened focus on the cardiometabolic risk factors that are closely tied to increasing trends in obesity and suboptimal lifestyle. Polycystic ovarian synd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::646d8c6b3b59f2a7602db8a69c3b5e99
https://pubmed.ncbi.nlm.nih.gov/33836983
https://pubmed.ncbi.nlm.nih.gov/33836983